PATIENT-GRAFT SURVIVAL ANALYSIS IN KIDNEY TRASPLANT WITH DECEASED DONOR IN CHILDREN IN ARGENTINA 1998-2009 Bisigniano Liliana MD., López-Rivera Arturo.

Slides:



Advertisements
Similar presentations
Changes in graft function in long term renal transplant recipients – analysis by CKD stage and recipient characteristics U.P.Udayaraj, D.Ansell, R.Steenkamp,
Advertisements

Chapter 7: Pediatric ESRD 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Risk of invasive H. influenzae disease in patients with chronic renal failure: a call for vaccination? M. Ulanova, S. Gravelle, N. Hawdon, S. Malik, D.
This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non-commercial study and educational.
Therapeutic Penetrating Keratoplasty in Fungal Keratitis: Prospective Study Sonika Gupta Consultant Ophthalmology Max Eye Care New Delhi, India Author.
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index American Journal of Transplantation 2006; 6: 783–790 S. Fenga, N.P.
Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients Deirdre Sawinski MD, Kimberly A.
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
The long-term outcome after acute renal failure Presented by Ri 顏玎安.
Impact of expanded criteria donors on patient survival after heart, lung, liver and combined organ transplantation Quebec experience from 2003 to 2009.
Recent management of Renal Transplantation in a Developing Country like Bangladesh, R Alam, Islam M S, R Alam, H Rahman, HU Rashid Department of Nephrology,
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results.
ESRD Prognosis ERA-EDTA vs. Danish Renal Registry James Heaf.
Living Donor Kidney Transplant. What does the evidence say about outcome ? Professor Peter J Conlon.
Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the NSW Southern Area.
© ANZOD Registry Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the.
Living Donor Kidneys in PAK 2/11 USA Primary DD Pancreas Transplants 1/1/1988 – 12/31/2010.
CORR Report, 2012: CST Annual General Meeting S. Joseph Kim, MD, PhD, FRCPC Vice President, CORR Board of Directors Friday, February 24,
PAIRED EXCHANGE KIDNEY TRANSPLANTATION EXPERIENCE OF TURKEY Levent Yucetin MD. Antalya Medicalpark Healthcare Group Transplant Center Senior Transplant.
INFLUENCE OF HLA MISMATCH ON GRAFT SURVIVAL IN RENAL TRASPLANTATION IN ADULTS IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
1 Influence of donor & recipient risk factors and the choice of immunosuppression Long term outcome after renal transplantation Influence of donor & recipient.
HEART TRANSPLANTATION Pediatric Recipients JHLT Oct; 32(10):
Terminology in Health Care and Public Health Settings Unit 12 Urinary System.
CHRONIC KIDNEY DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
The Expanded Criteria Donors in Kidney Transplantation: 3 Years Experience FAM Shaheen, B. Al-Attar, MZ Souqiyyeh, J.E Cillo, A. Al Sayyari.
12/2013 The Present Evolution of Liver Transplantation in Europe EUROPEAN LIVER TRANSPLANT REGISTRY 28 countries institutions 118,441 transplantations.
Factors Affecting Long-term First Renal Graft Survival Identified in a 10-year, 5-centre Retrospective National Study James Medcalf, John Bankart and Julie.
CHAPTER 5: PAEDIATRIC RENAL REPLACEMENT THERAPY Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Yap Yok Chin Wan Jazilah Wan Ismail Source: 21 st MDTR.
TRANSPLANTATION CHAPTER 8 ANZDATA Registry Annual Report 2013.
Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.
Fioretti S.; Antik A; Busto S; Bacque MC; Schiavelli R; Domenech A; Vallejos A. Analysis of Kidneys Procured by the Transplant Institute and DGF in Transplant.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
Minority Affairs Committee Fall  Patient resource promoting early referral for transplant evaluation  Collaborated with Patient Affairs Committee.
DONOR RISK INDEX-LIVER GRAFT SURVIVAL ASSOCIATION IN PATIENTS OVER 18 YEARS OF AGE IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
Histological markers of CNI nephrotoxicity: Specific or not specific? Marion Rabant MD, Renaud Snanoudj MD, Virginie Royal MD, C. Girardin, E.Morelon MD.
1 Kidney Transplantation Committee Spring Recent Public Comment Proposals  OPTN Kidney Paired Donation (KPD) Priority Points  Changes apply.
Transplantation in HIV+ Recipients Ron Shapiro, M.D. THOMAS E. STARZL TRANSPLANTATION INSTITUTE UNIVERSITY OF PITTSBURGH.
HEART-LUNG TRANSPLANTATION Pediatric Recipients 2015 JHLT Oct; 34(10):
Is BMI a Justified Contraindication for Kidney Transplantation? Introduction OHSU’s Kidney Transplant Program has set a BMI >35 kg/m 2 as a relative contraindication.
Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients.
R.Ibar, C.Soratti, M.Torres. A Quality Assurance Program in the procurement process that includes the monitoring of neurocritical patients with GCS ≤7.
Impact of Recipient and Donor Non-immunological factors on the Outcome of Expanded Criteria Deceased Donors Kidney Transplantation Dr Hajar Al Hayyan.
Figures from Dialysis and kidney transplantation in Australia 1991–2010.
SPECTRUM OF CHRONIC RENAL FAILURE King Hussein Medical Center Edward Saca MD, MSc.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
United States Organ Transplantation SRTR & OPTN Annual Data Report, 2011 Kidney.
INTRODUCTION. The annual incidence of liver transplant outcomes in South America has been unknown. So far direct correlations have been reported between.
Preemptive Kidney Transplant (PKT) – the Optimal Therapy in ESRD Reference: Connie L. Davis. Preemptive transplantation and the transplant first initiative.
The significance of Focal C4d+: The WU experience Helen Liapis, M.D. Professor of Pathology & immunology Kedainis RL et al. Am J Transplant Apr;9(4):812-9.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
SURVIVAL IN ADULTS UNDERGOING KIDNEY TRANSPLANT FROM CADAVERIC DONORS COMPARED WITH PATIENTS ON WAITING LIST IN ARGENTINA Bisigniano, Liliana.
2016 Annual Data Report, Vol 2, ESRD, Ch 8
Organ Failure in Nepal: Rapidly Growing Challenge for All
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Number of transplants, by donor type figure 8.1
Chapter 7: ESRD among Children, Adolescents, and Young Adults
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Number of Grafts Performed by Country
Liver only transplants in the UK Question 2: In terms of survival benefit.
EUROPEAN LIVER TRANSPLANT REGISTRY
Risk factors in deceased-donor transplants Risk factor 1988
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease  Sandra Amaral, Blayne A.
Worldwide incidence of ESRD figure 12.1, per million population
Cumulative survival curves for deceased-donor transplant recipients who were older than 70 yr and similarly aged dialysis patients who were on the waiting.
Presentation transcript:

PATIENT-GRAFT SURVIVAL ANALYSIS IN KIDNEY TRASPLANT WITH DECEASED DONOR IN CHILDREN IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi Viviana, Fernández Víctor J MD., Soratti Carlos A MD.

Introduction Thanks to advances in surgical techniques and immune system suppression, the mortality rate in children with chronic renal failure has dramatically declined. Kidney transplantation has become the standard of care for ESRD in the pediatric population

Objective To analyze the variables included in organ procurement, retrieval and transplantation associated to both patient and graft survival in kidney transplant using deceased donors in patients under 18 years of age.

Materials & Methods The information was obtained from SINTRA for the period The Kaplan-Meir method was used; survival at 30 days, 1, 5 and 10 yrs. was recorded. The Cox regression model was used to consider the variables for both patient and graft survival such as gender and age The MedCalc and SPSS 17 statistical packages were used

Materials & Methods Independent Variables Gender Donor´s Age Recipient´s Age CIT 24 hs Etiology of ERSD Time on Dialysis ( 7 yrs.) Cause of Donor´s Death Mismatch HLA from 0 to 6

Results Survival GENDER345 (54%) FEMALES AND 290 (46%) MALES AGE years MEAN FOLLOW UP4 YEARS (MAX 13 YEARS) PATIENTGRAFT 30 days 99.4%97.2% 1 st year 96.8%91.9% 5 years 91.1%79.3% 10 years 82.5%61.8%

Results Patient Survival Curve 30 days1 year5 years10 years 99.40%96.80%91.10%82.50%

Results Graft Survival Curve 30 days1 year5 years10 years 97.20%91.90%79.30%61.80%

Results Cox regression – patient survival VARIABLEHRIC 95%P Donor`s age years Donor`s age years Donor`s age >60 years--- Recipient`s age >12 years CIT > 24 hrs Obstructive nephropathy Glomerulonephritis Unknown Uremic Hemolytic Syndrome Renal polycystosis Interstitial tubulonephritis--- CVA Anoxia Other cause of coma Tumor < CNS infections--- Time on dialysis >7 years Female recipient Female donor

Results Cox regression – patient survival VARIABLEHRIC 95%P Donor`s age years Donor`s age years Donor`s age >60 years--- Recipient`s age >12 years CIT > 24 hrs Obstructive nephropathy Glomerulonephritis Unknown Uremic Hemolytic Syndrome Renal polycystosis Interstitial tubulonephritis--- CVA Anoxia Other cause of coma Tumor < CNS infections--- Time on dialysis >7 years Female recipient Female donor

RESULTS VARIABLEHRIC 95%P Donor`s age years Donor`s age years Donor`s age >60 years Recipient`s age >12 years CIT > 24 hrs Obstructive nephropathy Glomerulonephritis Unknown Uremic hemolytic syndrome Renal polycystosis Interstitial tubulonephritis CVA Anoxia Other cause of coma Tumor CNS infections--- Time on dialysis >7 years Female recipient Female donor Cox regression – graft survival

Conclusions Female gender as a donor or recipient, a recipient older than 12 and a tumor as the cause of death were associated with a worse survival rate for recipient. The donor´s age between 45 and 59 yrs., the presence of glomerulonephritis as the etiology of renal failure, CIT > 24hrs and time on dialysis >7 yrs. were associated with a lower graft survival rate.

Thank you for your attention